Nuclear Medicine and Biology
Volume 34, Issue 3 , Pages 283-291, April 2007

Synthesis and evaluation of a 99mTc-MAMA-propyl-thymidine complex as a potential probe for in vivo visualization of tumor cell proliferation with SPECT

  • Sofie Celen

      Affiliations

    • Laboratory for Radiopharmacy, K.U. Leuven, B-3000 Leuven, Belgium
  • ,
  • Tjibbe de Groot

      Affiliations

    • Radiopharmacy, U.Z. Gasthuisberg K.U. Leuven, B-3000 Leuven, Belgium
  • ,
  • Jan Balzarini

      Affiliations

    • Rega Institute for Medical Research, K.U. Leuven, B-3000 Leuven, Belgium
  • ,
  • Kathleen Vunckx

      Affiliations

    • Nuclear Medicine, U.Z. Gasthuisberg K.U. Leuven, B-3000 Leuven, Belgium
  • ,
  • Christelle Terwinghe

      Affiliations

    • Radiopharmacy, U.Z. Gasthuisberg K.U. Leuven, B-3000 Leuven, Belgium
  • ,
  • Peter Vermaelen

      Affiliations

    • Nuclear Medicine, U.Z. Gasthuisberg K.U. Leuven, B-3000 Leuven, Belgium
  • ,
  • Lizette Van Berckelaer

      Affiliations

    • Rega Institute for Medical Research, K.U. Leuven, B-3000 Leuven, Belgium
  • ,
  • Hubert Vanbilloen

      Affiliations

    • Radiopharmacy, U.Z. Gasthuisberg K.U. Leuven, B-3000 Leuven, Belgium
  • ,
  • Johan Nuyts

      Affiliations

    • Nuclear Medicine, U.Z. Gasthuisberg K.U. Leuven, B-3000 Leuven, Belgium
  • ,
  • Luc Mortelmans

      Affiliations

    • Nuclear Medicine, U.Z. Gasthuisberg K.U. Leuven, B-3000 Leuven, Belgium
  • ,
  • Alfons Verbruggen

      Affiliations

    • Laboratory for Radiopharmacy, K.U. Leuven, B-3000 Leuven, Belgium
  • ,
  • Guy Bormans

      Affiliations

    • Laboratory for Radiopharmacy, K.U. Leuven, B-3000 Leuven, Belgium
    • Corresponding Author InformationCorresponding author. Laboratorium for Radiopharmacy, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium. Tel.: +32 16 330447; fax: +32 16 330449.

Received 19 November 2006; received in revised form 18 December 2006; accepted 5 January 2007.

Abstract 

Introduction

Cytosolic thymidine kinase (TK1) catalyzes phosphorylation of thymidine to its monophosphate. TK1 activity is closely related with DNA synthesis, and thymidine analogs derivatized with bulky carboranylalkyl groups at the N-3 position were reported to be good substrates for TK1. Accordingly, we have synthesized 99mTc-MAMA-propyl-thymidine and evaluated it as a potential tumor tracer.

Methods

The bis(S-trityl)-protected MAMA-propyl-thymidine precursor (3-N-[S-trityl-2-mercaptoethyl]-N-[N′-(S-trityl-2-mercaptoethyl)amidoacetyl]-aminopropyl-thymidine) was prepared in three steps, and its structure was confirmed with 1H NMR and mass spectrometry. Deprotection of the thiols and labeling with 99mTc were done in a two-step, one-pot procedure, yielding 99mTc-MAMA-propyl-thymidine, which was analyzed with high-performance liquid chromatography, radio-LC-MS analysis (ESI+) and electrophoresis, and its log P was determined. The biodistribution in normal mice was evaluated, and its biodistribution in a radiation-induced fibrosarcoma (RIF) tumor mouse was compared with that of 3′-deoxy-3′-[18F] fluorothymidine [18F]FLT.

Results

99mTc-MAMA-propyl-thymidine was obtained with a radiochemical yield of 70%. Electrophoresis indicated that the complex is uncharged, and its log P was 1.0. The molecular ion mass of the Tc complex was 589 Da, which is compatible with the hypothesized N2S2-oxotechnetium structure. Tissue distribution showed fast clearance from plasma primarily by the hepatobiliary pathway. Whole-body planar imaging after injection of 99mTc-MAMA-propyl-thymidine in an RIF tumor-bearing mouse showed high uptake in the liver and the intestines. No uptake was observed in the tumor, in contrast to the clear uptake observed for [18F] FLT visualized with μPET.

Conclusions

Although it has been reported that TK1 accepts large substituents at the N-3 position of the thymine ring, the results of this study show that 99mTc-MAMA-propyl-thymidine cannot be used as a single photon emission computed tomography tumor tracer, probably because the 99mTc-MAMA ligand is too bulky to be tolerated by TK1.

Keywords: Thymidine, Technetium-99m, TK1, RIF tumor, Radio-LC-MS

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0969-8051(07)00010-8

doi:10.1016/j.nucmedbio.2007.01.003

Nuclear Medicine and Biology
Volume 34, Issue 3 , Pages 283-291, April 2007